The oncogenic roles of p53 mutants in mouse models

被引:60
|
作者
Lozano, Guillermina [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA
关键词
D O I
10.1016/j.gde.2006.12.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumors associated with p53 usually contain missense mutations in the p53 tumor suppressor gene rather than deletions of p53, suggesting a growth advantage for cells with missense mutations. The oncogenic roles of p53 mutants have been examined extensively in cell lines. Mouse models that inherit p53 mutations expressed at physiological levels have now been generated to examine the activities of mutant p53 upon tumorigenesis in vivo. Mice with p53 mutations develop tumor spectrums and metastatic phenotypes different from those of mice with a p53-null allele. Embryo fibroblasts with mutant p53 also show increased proliferative and transformation properties. One mechanism for this gain-of-function potential is the inhibition of function of the p53 family members p63 and p73.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 50 条
  • [1] p53 mutants without a functional tetramerisation domain are not oncogenic
    Chène, P
    Bechter, E
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (05) : 1269 - 1274
  • [2] Mouse Models of p53 Functions
    Lozano, Guillermina
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (04): : a001115
  • [3] Oncogenic morphs of p53
    Gemma K. Alderton
    Nature Reviews Cancer, 2012, 12 : 155 - 155
  • [4] Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
    Li, Hui
    Zhang, Jinglin
    Tong, Joanna Hung Man
    Chan, Anthony Wing Hung
    Yu, Jun
    Kang, Wei
    To, Ka Fai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [5] MORPHOLOGY Oncogenic morphs of p53
    Alderton, Gemma K.
    NATURE REVIEWS CANCER, 2012, 12 (03) : 155 - 155
  • [6] Development of mouse models of angiosarcoma driven by p53
    Salter, Donald M.
    Griffin, Meredyth
    Muir, Morwenna
    Teo, Katy
    Gulley, Jayne
    Smith, James R.
    Gomez-Cuadrado, Laura
    Matchett, Kylie
    Sims, Andrew H.
    Hayward, Larry
    Henderson, Neil C.
    Brunton, Valerie G.
    DISEASE MODELS & MECHANISMS, 2019, 12 (07)
  • [7] Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ)
    Degtjarik, Oksana
    Golovenko, Dmitrij
    Diskin-Posner, Yael
    Abrahmsen, Lars
    Rozenberg, Haim
    Shakked, Zippora
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [8] Multi-way Restoration of the Function of p53 Oncogenic Mutants by Suppressor Mutations.
    Diskin-Posner, Y.
    Rozenberg, H.
    Diskin-Posner, Y.
    Eldar, A.
    Shakked, Z.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2013, 69 : S318 - S318
  • [9] Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
    Lu Yang
    Yun Li
    Arup Bhattacharya
    Yuesheng Zhang
    Communications Biology, 4
  • [10] A peptide that binds and stabilizes p53 core domain:: Chaperone strategy for rescue of oncogenic mutants
    Friedler, A
    Hansson, LO
    Veprintsev, DB
    Freund, SMV
    Rippin, TM
    Nikolova, PV
    Proctor, MR
    Rüdiger, S
    Fersht, AR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 937 - 942